Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

Overview of attention for article published in Influenza & Other Respiratory Viruses, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)

Mentioned by

twitter: 4 X users
patent: 4 patents

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

Readers on

mendeley: 123 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 15,652 followers.

If you're interested in RSV vaccine development you might find this review interesting (it's by me 😜) #Microbio17 https://t.co/WrBLM4CYRV

RSV an expert commentary on RSV prophylactic and therapeutic pharmaceuticals http://t.co/yDQYvjIb37 http://t.co/xg5A2zc1AQ

@MeyerBjoern This is a good summary of the current RSV pharmaceuticals in clinical trials! http://t.co/mibsrIWkDp

http://t.co/AyBN3GNaSV Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on RSV drugs... I wrote this :)

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.